SICC Co., Ltd. (02631) received a total reduction of 3.0316 million shares of the company's stock from Hubble Investments.

19:49 17/12/2025

Tianyue Advanced (02631) announced that from October 28, 2025 to December 16, 2025, Haubo Investment reduced its holdings of the company's shares by 3.0316 million shares through centralized bidding trading. Before this equity change, Haubo Investment held 27.2625 million shares of the company, accounting for 6.34% of the total share capital of the company (total share capital calculated based on the number of shares before the issuance of H shares). After this equity change, Haubo Investment held 24.2309 million shares of the company, accounting for 5.00% of the total share capital of the company (total share capital calculated based on the number of shares after the issuance of H shares), triggering the 5% threshold of equity change.

SICC Co., Ltd. (02631) announced that from October 28, 2025 to December 16, 2025, Hubble Investment reduced its holding of the company's shares by 3.03 million shares through centralized bidding trading. Prior to this equity change, Hubble Investment held 27.26 million shares of the company, accounting for 6.34% of the total share capital of the company (total share capital calculated before the issuance of H shares). After this equity change, Hubble Investment holds 24.23 million shares of the company, accounting for 5.00% of the total share capital of the company (total share capital calculated after the issuance of H shares), triggering the 5% threshold for equity changes.

LIANLIAN (02598) spent HKD 996,500 on December 17 to repurchase 158,500 shares.

Nebius (NBIS.US) releases the next generation AI cloud platform powered by the NVIDIA Corporation Blackwell Ultra chip to compete against CoreWeave.

BIOSTAR PHARM-B(02563): Yutidelong treatment of brain metastases in breast cancer, the first patient in the United States treated with key clinical research.

LIANLIAN (02598) spent HKD 996,500 on December 17 to repurchase 158,500 shares.

Nebius (NBIS.US) releases the next generation AI cloud platform powered by the NVIDIA Corporation Blackwell Ultra chip to compete against CoreWeave.

BIOSTAR PHARM-B(02563): Yutidelong treatment of brain metastases in breast cancer, the first patient in the United States treated with key clinical research.